Cannabinoid
Cannabidiol for Parkinson's Disease
Recruiting0 awardsPhase 2
Aurora, Colorado
The major purpose of this study is to assess the efficacy of CBD on motor symptoms of Parkinson's Disease (PD), and secondarily to study the safety and tolerability of CBD and other efficacy, particularly regarding tremor in PD. The study has been powered to detect a clinically significant reduction in Movement Disorder Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III motor scores. This is a 1:1 parallel, double-blind, randomized controlled trial (RCT) with 60 participants. The investigators will be recruiting up to 75 participants; the goal is to have 60 participants (30 in CBD group and 30 in placebo group) complete the study. The study drug is obtained from the National Institute on Drug Abuse (NIDA).
Behavioural Intervention
Walking Program + mHealth for Parkinson's Disease
Recruiting1 award
Boston, Massachusetts
This trial is testing the benefits of a walking program, exercises to improve walking, and cognitive-behavioral strategies delivered using mobile health technology for people with Parkinson disease.
Popular Filters
Trials for Parkinson's Disease Patients
Non-invasive Brain Stimulation
tDCS for Cognitive Impairment in Parkinson's Disease
Recruiting0 awards5 criteria
Winnipeg, Manitoba
This trial aims to use a novel personalized network analysis approach to elucidate the mechanisms of the effect of tDCS on cognitive dysfunction in non-demented PD patients.
Mucolytic Agent
Ambroxol for Parkinson's Disease Dementia
Recruiting1 awardPhase 2
London, Ontario
This trial tests if Ambroxol, a safe over-the-counter medication, can help people with Parkinson's Disease Dementia by increasing an enzyme that reduces harmful proteins in the brain. The goal is to see if it improves memory and movement problems. Ambroxol has been shown to be safe and well tolerated in previous studies.
Behavioural Intervention
Physical Therapy + Medication for Parkinson's Disease
Recruiting1 awardPhase < 1
Cleveland, Ohio
This trial will compare physical therapy alone to physical therapy plus medication (either low dose methylphenidate or atomoxetine) to see if the addition of medication leads to more improvement in gait and balance in patients with Parkinson disease.
Dopamine Precursor
Continuous Subcutaneous Infusion of Levodopa/Carbidopa for Parkinson's Disease
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial tests a pump that delivers medication under the skin for patients with advanced Parkinson's Disease. The treatment aims to improve movement symptoms by increasing dopamine levels in the brain. This method has been used for many years to manage motor complications in advanced Parkinson's Disease.
Trials for PD Patients
Non-invasive Brain Stimulation
tDCS for Cognitive Impairment in Parkinson's Disease
Recruiting0 awards5 criteria
Winnipeg, Manitoba
This trial aims to use a novel personalized network analysis approach to elucidate the mechanisms of the effect of tDCS on cognitive dysfunction in non-demented PD patients.
Mucolytic Agent
Ambroxol for Parkinson's Disease Dementia
Recruiting1 awardPhase 2
London, Ontario
This trial tests if Ambroxol, a safe over-the-counter medication, can help people with Parkinson's Disease Dementia by increasing an enzyme that reduces harmful proteins in the brain. The goal is to see if it improves memory and movement problems. Ambroxol has been shown to be safe and well tolerated in previous studies.
Behavioural Intervention
Physical Therapy + Medication for Parkinson's Disease
Recruiting1 awardPhase < 1
Cleveland, Ohio
This trial will compare physical therapy alone to physical therapy plus medication (either low dose methylphenidate or atomoxetine) to see if the addition of medication leads to more improvement in gait and balance in patients with Parkinson disease.
Dopamine Precursor
Continuous Subcutaneous Infusion of Levodopa/Carbidopa for Parkinson's Disease
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial tests a pump that delivers medication under the skin for patients with advanced Parkinson's Disease. The treatment aims to improve movement symptoms by increasing dopamine levels in the brain. This method has been used for many years to manage motor complications in advanced Parkinson's Disease.
Trials With No Placebo
Behavioural Intervention
Physical Therapy + Medication for Parkinson's Disease
Recruiting1 awardPhase < 1
Cleveland, Ohio
This trial will compare physical therapy alone to physical therapy plus medication (either low dose methylphenidate or atomoxetine) to see if the addition of medication leads to more improvement in gait and balance in patients with Parkinson disease.
Dopamine Precursor
Continuous Subcutaneous Infusion of Levodopa/Carbidopa for Parkinson's Disease
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial tests a pump that delivers medication under the skin for patients with advanced Parkinson's Disease. The treatment aims to improve movement symptoms by increasing dopamine levels in the brain. This method has been used for many years to manage motor complications in advanced Parkinson's Disease.
Nerve Grafts + DBS Surgery for Parkinson's Disease
Recruiting1 awardPhase 1
Lexington, Kentucky
This trial tests the safety of implanting a patient's own nerve tissue into their brain during surgery for Parkinson's disease. The goal is to use natural substances from the nerve tissue to help protect and repair brain cells affected by the disease.
Behavioural Intervention
CranioSacral Therapy for Parkinson's Disease
Recruiting1 award1 criteria
Ann Arbor, Michigan
This trial is studying the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients. This therapy is given biweekly for 3 months, and the investigators expect to see a positive change in the symptoms of the patients.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.